|
| Patients | Patients with Diabetes Mellitus, | Patients without Diabetes Mellitus, | p-Value | Patients with Hyperglycemia on Admission | Patients without Hyperglycemia on Admission | P-Value |
| No. patients | 551 | 113 (20.5%) | 438 (79.5%) |
| 289 (52.5%) | 262 (47.5%) | 0.214 |
| Age, Median (range) | 56 (23 - 88) | 61 (34 - 88) | 54 (23 - 71) |
| 52 (23 - 88) | 58 (27 - 74) | 0.37 |
| Male, NO. (%) | 286 (51.9%) | 101 (52.7%) | 185 (51.7%) | 0.961 | 152 (52.6%) | 134 (51.1%) | 0.952 |
| *GCS, NO. (%) |
|
|
| <0.01 |
|
| <0.01 |
| <8 | 231 (41.9%) | 113 (58.5%) | 118 (33.0%) |
| 167 (57.8%) | 64 (24.4%) |
|
| >8 | 320 (58.1%) | 80 (41.5%) | 240 (67.0%) |
| 122 (42.2%) | 198 (75.6) |
|
| *Site of ICH, NO. (%) |
|
|
|
|
|
|
|
| Thalamus | 86 (15.6%) | 26 (13.5%) | 60 (16.8%) | 0.683 | 42 (14.5%) | 44 (16.8%) | 0.732 |
| Basal ganglia | 262 (47.5%) | 91 (47.2%) | 171 (47.8%) | 0.954 | 148 (51.2%) | 114 (43.5%) | 0.747 |
| Lobar | 107 (19.4%) | 28 (14.5%) | 79 (22.1%) | 0.031 | 48 (16.6%) | 59 (22.5%) | 0.042 |
| Pons | 66 (12.0%) | 36 (18.7%) | 30 (8.4%) | <0.010 | 34 (11.8%) | 32 (12.2%) | 0.864 |
| Cerebellum | 30 (5.5%) | 12 (6.1%) | 18 (4.9%) | 0.385 | 17 (5.9%) | 13 (5.0%) | 0.912 |
| *ICH volume, NO. (%) |
|
|
| <0.01 |
|
| <0.01 |
| Small (<30 mL) | 289 (52.5%) | 69 (35.8%) | 220 (61.5%) |
| 122 (42.2%) | 167 (63.7%) |
|
| Large (>30 mL) | 262 (47.5%) | 124 (64.2%) | 138 (38.5%) |
| 167 (57.8%) | 95 (36.3%) |
|
| EVD, NO. (%) | 235 (42.6%) | 104 (53.9%) | 131 (36.6%) | <0.01 | 197 (68.2%) | 38 (14.5%) | <0.01 |
| IVH, NO. (%) | 85 (15.4%) | 52 (26.9%) | 33 (9.2%) | <0.01 | 63 (21.8%) | 22 (8.4%) | <0.01 |
| Medical history, NO. (%) |
|
|
|
|
|
|
|
| Abnormal liver function | 15 (2.7%) | 7 (3.6%) | 8 (2.1%) | 0.357 | 9 (3.1%) | 6 (2.3%) | 0.342 |
| Renal insufficiency | 26 (4.7%) | 14 (7.3%) 11 | 12 (3.4%) | 0.003 | 15 (5.2%) | 11 (4.2%) | 0.417 |
| History of pneumonia | 98 (17.8%) | 45 (23.3%) | 54 (15.1%) | <0.01 | 61 (21.1%) | 37 (14.1%) | <0.01 |
| History of stroke | 103 (18.7%) | 61 (31.6%) | 42 (11.7%) | <0.01 | 57 (19.7%) | 46 (17.6%) | 0.364 |
| *Initial laboratories |
|
|
|
|
|
|
|
| WBC, median (IQR) | 6.7 (3.5 - 21.3) | 5.9 (3.5 - 19.8) | 7.6 (5.1 - 21.3) | 0.119 | 8.9 (6.3 - 21.3) | 5.2 (3.5 - 17.8) | <0.01 |
| Initial blood glucose median (IQR) | 8.7 (5.1 - 19) | 10.4 (7.9 - 17.8) | 9.7 (5.1 - 19) | 0.845 | 13.2 (11.6 - 19) | 7.3 (5.1 - 11) | <0.01 |
| HbA1C, median (IQR) | 5.7 (4.5 - 9.6) | 6.7 (6.1 - 9.6) | 4.5 (4.5 - 5.9) | <0.01 | 6.2 (4.8 - 9.6) | 5.9 (4.5 - 7.8) | 0.253 |